MIRA INFORM REPORT

 

 

Report Date :

18.06.2013

 

IDENTIFICATION DETAILS

 

Name :

INDUSTRIAS BIOQUIMICAS S.A

 

 

Registered Office :

Km 27.2 Carretera a El Salvador, Municipio de Fraijanes, C.P. 01065, Ciudad de Guatemala

 

 

Country :

Guatemala

 

 

Date of Incorporation :

03.07.1995

 

 

Com. Reg. No.:

Deed No. 155

 

 

Legal Form :

Stock Company

 

 

Line of Business :

Manufacturer of Pharmaceutical, Botanical Products and Medicinal Substances

 

 

No. of Employees :

200

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit : 

US$30,000.00 Dollars

Status :

Moderate  

Payment Behaviour :

Unknown 

Litigation :

Clear 

 


NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

Guatemala

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

Guatemala ECONOMIC OVERVIEW

 

Guatemala is the most populous country in Central America with a GDP per capita roughly one-half that of the average for Latin America and the Caribbean. The agricultural sector accounts for 13% of GDP and 38% of the labor force; key agricultural exports include coffee, sugar, bananas, and vegetables. The 1996 peace accords, which ended 36 years of civil war, removed a major obstacle to foreign investment, and since then Guatemala has pursued important reforms and macroeconomic stabilization. The Dominican Republic-Central American Free Trade Agreement (CAFTA-DR) entered into force in July 2006 spurring increased investment and diversification of exports, with the largest increases in ethanol and non-traditional agricultural exports. While CAFTA-DR has helped improve the investment climate, concerns over security, the lack of skilled workers and poor infrastructure continue to hamper foreign direct investment. The distribution of income remains highly unequal with the richest 20% of the population accounting for more than 51% of Guatemala''s overall consumption. More than half of the population is below the national poverty line and 13% of the population lives in extreme poverty. Poverty among indigenous groups, which make up 38% of the population, averages 73% and extreme poverty rises to 28%. Nearly one-half of Guatemala''s children under age five are chronically malnourished, one of the highest malnutrition rates in the world. Given Guatemala''s large expatriate community in the United States, it is the top remittance recipient in Central America, with inflows serving as a primary source of foreign income equivalent to nearly two-fifths of exports or one-tenth of GDP. Economic growth fell in 2009 as export demand from US and other Central American markets dropped and foreign investment slowed amid the global recession. The economy gradually recovered in 2010-12.

 

Source : CIA

 

 

REGISTERED NAME & COMPANY SUMMARY

 

IDENTIFICATION

COMPANY NAME

INDUSTRIAS BIOQUIMICAS S.A

TRADE NAME

INDUSTRIAS BIOQUIMICAS

TAX ID TYPE

NIT

TAX ID NUMBER

771037-2

CURRENT STATUS

Active

MAIN ADDRESS

Km 27.2 Carretera a El Salvador, Municipio de Fraijanes

CITY/PROVINCE/STATE

C.P. 01065, Ciudad de Guatemala

PHONE NUMBER(S)

(502)6634.3534

FAX NUMBER

(502)6634.4914

E-MAIL

ib.gerencia@grupopharma.com.gt

WEB SITE

www.gurpopharma.com.gt  (Corporate's website)

PAYMENT HISTORY

EP. A: PAYMENTS USUALLY PROMPT

COMMENTS OF IDENTIFICATION.-

The supplied address: Km. 27.2 Carretera a El Salvador, Fraijanes, Guatemala, is inexact. Please be advised that the correct and complete spelling form of this address is as mention in caption.

 

LEGAL ASPECTS

LEGAL STATUS

Stock Company

INCORPORATION DATE

03/07/1995

REGISTERED IN

Guatemala City

DURATION

Unlimited

REGISTRATION

Deed No. 155

INITIAL CAPITAL

Q.5,000.00 Quetzales

LISTED AT STOCK EXCHANGE

NO

RATE OF EXCHANGE

US$1.00 = Q.7.84 (as of report date)

 

COMMENTS ON LEGAL ASPECTS .-

On 03/07/1995, Subject was incorporated by Deed No.155 On 02/08/1995, it was provisionally registered in the Commercial Registry of Guatemala, until 06/11/1995, when it was definitely registered. On 02/08/1995, It was also registered in the Superintendency of Tax Administration (SAT) The subject company is registered in the Contracting and Acquisition System of Guatemala. It is also member of the Chamber of Industry of Guatemala - CIG.

 

CREDIT RECOMENDATION

 

Current Credit Limit: US$30,000.00 Dollars

 

DIRECTORS/MANAGEMENT

 

BOARD OF DIRECTORS-EXECUTIVES-SHAREHOLDERS

NAME

JOB TITLE

% STAKE

LUNA DEL PINAR, RODOLFO

President/Legal Rep./Majority Shareholder

YES

CORADO CUEVAS, CLAUDIA INES

General Manager/Legal Rep.

 

GARCIA , FELIPE

Finance Manager

 

 

NEGATIVE INFORMATION

 

LITIGATIONS

No detrimental against company name.

 

SHARE & SHARE CAPITAL INFORMATION

 

INITIAL CAPITAL

Q.5,000.00 Quetzales

 

PAYMENT INFORMATION

 

PAYMENTS

TRADE REFERENCES

TYPE OF SUPPLIER

NATIONAL

ACCOUNT OPENED

Several years ago

CREDIT FACILITIES

No current operations limit

MONTHLY AVERAGE

Q.25,000.00 to Q.30,000.00

DEADLINES

Invoices at 30 days

PRODUCTS SOLD

Plastic bags

RATING

PROMPT

COMMENTS.-

Payments by checks Last purchase: In March 2013

 

TYPE OF SUPPLIER

NATIONAL

ACCOUNT OPENED

15 years ago

CREDIT FACILITIES

US$25,000.00

MONTHLY AVERAGE

US$5,000.00

DEADLINES

at 120 days

PRODUCTS SOLD

Not specified

RATING

PROMPT

COMMENTS.-

Payments via wire transfers Last purchase: In June 2013

 

CREDIT FILES

The other local supplier did not provide information on clients due to confidentiality policies.

 

GROUP STRUCTURE & AFFILIATED COMPANIES

 

RELATED COMPANIES

NAME

TAX ID. NUMBER

COUNTRY

FARMACIAS DE LA COMUNIDAD SA

7964242

GUATEMALA

FARMALAB SA

 

GUATEMALA

GRUPO PHARMA SA

12775487

GUATEMALA

 

COMMENTS RELATED COMPANIES

The subject is related to the following companies: - GRUPO PHARMA SA, engaged in distribution of medicines to other pharmacies (which are not related to Subject). - FARMACIAS DE LA COMUNIDAD SA (chain of pharmacies) - FARMALAB SA, engaged in distribution of medicines at institutional level, mainly in the state sector.

 

FINANCIAL INFORMATION

 

FINANCIAL INFORMATION

CONTENT.-

The data comprised herein has been gathered from outside sources of consultation, in view of when contacting the Subject, head executives flatly denied to furnish information on the grounds of strict confidence. They also seemed to be unwilling to collaborate with us. Our investigation through the outside sources showed no financial data about the subject. The Subject is a company incorporated in 1995, which operations seem to be conducted normally. COUNTRY CONTEXT - GUATEMALA: The below information has been obtained from a highly regarded public source that issues comments on all of worlds? countries. Taxes: · Guatemalan income tax: 5% on the net profit-business: · Alphabetic currency code for every country by the International Organization for Standardization (ISO) 4217:Quetzal (GTQ). Main economic indicators: · External debt: US$16.17 billion (31 December 2012 est.) · International net reserves: US$6.311 billion (31 December 2012 est.) · Inflation rate forecasted : 4% (2012 est.) · GDP real growth rate: 3.1% (2012 est.) · Annual GDP per capita: US$5,200 (2012 est.) GDP - composition by sector: agriculture: 13% industry: 23.8% services: 63.2% (2012 est.) · Labuor force of 5.571 million people divided by: agriculture: 38% industry: 14% services: 48% Unemployment rate: 4.1% (2011 est.) Productivity sectors: Agriculture - products: sugarcane, corn, bananas, coffee, beans, cardamom; cattle, sheep, pigs, chickens · Industrial- products:: sugar, textiles and clothing, furniture, chemicals, petroleum, metals, rubber, tourism Foreign trade: Exports: US$9.864 billion (2012 est.) country comparison to the world: 95 Exports - commodities: coffee, sugar, petroleum, apparel, bananas, fruits and vegetables, cardamom Exports - partners: US 37.9%, El Salvador 10.5%, Honduras 6.8%, Mexico 5.1% Imports: US$15.57 billion (2012 est.) country comparison to the world: 86 Imports - commodities: fuels, machinery and transport equipment, construction materials, grain, fertilizers, electricity, mineral products, chemical products, plastic materials and products Imports - partners: US 40.4%, Mexico 11.6%, China 8.2%, El Salvador 4.5% Final Brief: Commercial Country Risk: LOW Political Country Risk: LOW

INSURANCE.-

It holds all loss insurance policy with SEGUROS G Y T SA. (Coverage amount neither maturity date were supplied).

 

FOREIGN EXCHANGE RATES

 

RATE OF EXCHANGE

US$1.00 = Q.7.84 (as of report date)

 

ADDITIONAL INFORMATION

 

OPERATIONS

SECTOR

1.-INDUSTRY

ACTIVITY

PHARMACEUTICALS/CHEMICALS/LABORATORIES

ISIC CATEGORY

D-MANUFACTURING INDUSTRIES (ELABORATION, MANUFACTURING, PRODUCTION, PUBLISHING, CASTING, CONSTRUCTION)

ISIC CLASS

2423-Manufacture of Pharmaceutical, Botanical Products and Medicinal Substances

MAIN ACTIVITY

Pharmaceutical laboratory (Human Medicine).

% CASH SALES/PAYMENT METHOD

60%

% CREDIT SALES/TERMS

40% (Terms at 30, 60 days)

TERRITORY OF SALES

90% (national market)

% FOREIGN SALES

10%

N. OF EMPLOYEES

200

 

COMMENTS OF OPERATIONS.-

It trades 100% wholesaling. Its sales are addressed to related companies. The Subject participated through "Farmacias de la Comunidad" with 28% of the market according to Rodolfo Luna del Pinar, Chairman of Pharma Group which is composed among others by "Industrias Bioquimicas SA. It imports raw material and packaging material from Switzerland, Spain, Germany and USA through direct credit from 30 until 90 days. It exports to Mexico, USA, El Salvador, Panama. The subject company is registered in the Contracting and Acquisition System of Guatemala, which reports the following award: - 2010: Q.179,300.00 Quetzales Major clients include: Ministry of Health Ministry of Communication, Infrastructure and Housing International Organization for Migration

 

LOCATION

ADMINISTRATIVE OFFICES, PLANT: Located at caption address. Own premises kept in good repair on grounds of 8,000 sq.m.

 

LOCAL SUPPLIERS

Name

Contact

Telephone

QUIMICA UNIVERSAL DE CENTROAMERICA SA

Maria del Carmen Morales

(502)2250.1040

ENVASES FLEXIBLES SA

 

 

REAL PLASTIK SA

Eugenia Leiva

(502)2247.0500

 

FOREIGN SUPPLIERS

Name

Contact

Telephone/fax

Country

INDUSTRIA QUIMICA ANDINA Y CIA. SA

 

 

COLOMBIA

 

BANKERS / REFERENCE

Bank Name

Account Number

Account Officer

Telephone

Country

BANCO DE AMERICA CENTRAL SA - BAC

 

 

 

GUATEMALA

BANCO REFORMADOR SA

 

 

 

GUATEMALA

BANCO DE DESARROLLO RURAL SA

 

 

 

GUATEMALA

BANK COMENTS

The above banks consulted did not provide references by preserving confidentiality of bank-client information.

 

NOTES & COMMENTS

 

CREDIT OPINION

Well-reputed company nationwide, which operations are conducted satisfactorily, It holds of good trade relations with suppliers. Nothing unfavourable learned. Hence, we estimate that it is suitable to deal with a credit line of US$30,000.00 Dollars.

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.57.73

UK Pound

1

Rs.90.61

Euro

1

Rs.76.96

 

INFORMATION DETAILS

 

Report Prepared by :

MNL

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.